Skip to Content
MilliporeSigma

Key Documents

View All Documentation

Skip To

63175

4-Maleimidobutyric acid N-hydroxysuccinimide ester

≥98.0% (HPLC)

Synonym(s):

4-Maleimidobutyric acid N-succinimidyl ester, N-(γ-Maleimidobutyryloxy)succinimide, N-Succinimidyl 4-maleimidobutyrate, GMBS

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View
Pack SizeSKUAvailabilityPrice
100 mg

Available to ship TODAYfromMILWAUKEE

$397.00

About This Item

Empirical Formula (Hill Notation):
C12H12N2O6
CAS Number:
80307-12-6
Molecular Weight:
280.23
UNSPSC Code:
12352106
NACRES:
NA.25
PubChem Substance ID:
329759802
MDL number:
MFCD00036817
Beilstein/REAXYS Number:
6427689
Assay:
≥98.0% (HPLC)

$397.00

Available to ship TODAYDetails

​
Request a Bulk Order
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

Quality Level

100

assay

≥98.0% (HPLC)

reaction suitability

reagent type: linker

mp

123-129 °C

functional group

NHS ester

storage temp.

2-8°C

SMILES string

O=C1N(CCCC(ON2C(CCC2=O)=O)=O)C(C=C1)=O

InChI

1S/C12H12N2O6/c15-8-3-4-9(16)13(8)7-1-2-12(19)20-14-10(17)5-6-11(14)18/h3-4H,1-2,5-7H2

InChI key

PVGATNRYUYNBHO-UHFFFAOYSA-N

Application

A heterobifunctional cross-linking reagent with amine and sulfhydryl reactivity. Typically, coupled initially to molecules containing primary amines by amide bonds buffered at pH 7.5 (6.5-8.5). Second coupling specific for molecules containing free sulfhydryl by thioether linkage buffered at pH 6.8 (6.5-7.0). Useful for preparation of enzyme immunoconjugates and hapten carrier molecule conjugates. Provides a 7-atom linker.

Compare Similar Items

View Full Comparison

Show Differences

1 of 1

This Item
6317963177358657
4-Maleimidobutyric acid N-hydroxysuccinimide ester ≥98.0% (HPLC)

Sigma-Aldrich

63175

4-Maleimidobutyric acid N-hydroxysuccinimide ester

3-(Maleimido)propionic acid N-hydroxysuccinimide ester ≥98.5% (HPLC)

Sigma-Aldrich

63179

3-(Maleimido)propionic acid N-hydroxysuccinimide ester

6-Maleimidohexanoic acid N-hydroxysuccinimide ester ≥98.0% (HPLC)

Sigma-Aldrich

63177

6-Maleimidohexanoic acid N-hydroxysuccinimide ester

3-Maleimidopropionic acid N-hydroxysuccinimide ester 99%

Sigma-Aldrich

358657

3-Maleimidopropionic acid N-hydroxysuccinimide ester

assay

≥98.0% (HPLC)

assay

≥98.5% (HPLC)

assay

≥98.0% (HPLC)

assay

99%

Quality Level

100

Quality Level

200

Quality Level

200

Quality Level

200

reaction suitability

reagent type: linker

reaction suitability

reagent type: linker

reaction suitability

reagent type: linker

reaction suitability

reagent type: linker

mp

123-129 °C

mp

167-171 °C

mp

70-73 °C (lit.)

mp

168-170 °C (lit.)

storage temp.

2-8°C

storage temp.

2-8°C

storage temp.

−20°C

storage temp.

2-8°C

functional group

NHS ester

functional group

NHS ester

functional group

NHS ester

functional group

NHS ester

Storage Class

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

dust mask type N95 (US), Eyeshields, Gloves

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
BCCM0539
BCCM0407
BCBV0406
BCBV3389
SLBH6654

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Markus Mandler et al.
Alzheimer's & dementia : the journal of the Alzheimer's Association, 15(9), 1133-1148 (2019-08-06)
Immunotherapeutic approaches targeting amyloid β (Aβ) protein and tau in Alzheimer's disease and α-synuclein (α-syn) in Parkinson's disease are being developed for treating dementia with Lewy bodies. However, it is unknown if single or combined immunotherapies targeting Aβ and/or α-syn
Yan Zhao et al.
Molecular pharmaceutics, 15(7), 2559-2569 (2018-05-17)
Photodynamic therapy, a procedure that uses a photosensitizer to enable light therapy selectively at diseased sites, remains underutilized in oncological clinic. To further improve its cancer selectivity, we developed a polymeric nanosystem by conjugating a photosensitizer IRDye 700DX (IR700) and
Yu Zhang et al.
Cancer biology & therapy, 17(11), 1177-1187 (2016-10-22)
Circulating tumor cells (CTCs) have been proposed to be an active source of metastasis or recurrence of hepatocellular carcinoma (HCC). The enumeration and characterization of CTCs has important clinical significance in recurrence prediction and treatment monitoring in HCC patients. We
View All Related Papers

Global Trade Item Number

SKUGTIN
63175-25MG-F04061832860473
63175-100MG-F04061832860466

Questions

Reviews

No rating value

Active Filters